Video

Dr. Chen Highlights Incidence of CTCL

Pei-Ling Chen, MD, PhD, discusses the incidence of CTCL.

Pei-Ling Chen, MD, PhD, is a member of the Pathology and Cutaneous Oncology Departments at Moffitt Cancer Center and a member of the Moffitt Cutaneous Lymphoma Multidisciplinary Clinic specializing in cutaneous T-cell lymphoma (CTCL).

CTCL is a rare subset of non-Hodgkin lymphoma with an annual incidence of 7.7 cases per million persons, according the SEER data. The most common form of CTCL, mycosis fungoides (MF) accounts for upward of 60% of CTCLs. MF is characterized by cutaneous patch, plaque, or tumor lesions.

Dr Chen discusses the epidemiology, miology, prepresentation, and common forms of early- and advanced stage CTCL. Early-stage CTCL is incurable but treatable. Advanced disease can be disfiguring and fatal.

Related Videos
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center